Workflow
Plurifreeze
icon
Search documents
Teknova(TKNO) - 2025 Q1 - Earnings Call Transcript
2025-05-08 22:02
Alpha Teknova (TKNO) Q1 2025 Earnings Call May 08, 2025 05:00 PM ET Company Participants Jennifer Henry - Senior Vice President of MarketingStephen Gunstream - President & CEOMatthew Lowell - Chief Financial OfficerVidyun Bais - Equity Research - Vice PresidentChad Wiatrowski - VP - Equity Research Conference Call Participants Anna Snopkowski - Equity Research AnalystMatthew Hewitt - Senior Research AnalystMatt Larew - Research Analyst - Healthcare Operator Good day, and thank you for standing by. Welcome t ...
Teknova(TKNO) - 2025 Q1 - Earnings Call Transcript
2025-05-08 22:00
Alpha Teknova (TKNO) Q1 2025 Earnings Call May 08, 2025 05:00 PM ET Speaker0 Good day, and thank you for standing by. Welcome to the Tecnova First Quarter twenty twenty five Financial Results Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. To ask a question during the session, you will need to press 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw y ...
Teknova(TKNO) - 2025 Q1 - Earnings Call Presentation
2025-05-08 20:36
FINANCIAL RESULTS: Q1:2025 SLIDE SUPPLEMENT Nasdaq: TKNO May 8, 2025 • Welcome • Business Highlights and Updates Stephen Gunstream, President and Chief Executive Officer • Financial Results and 2025 Outlook Matt Lowell, Chief Financial Officer • Q&A Forward-looking statements and use of non-GAAP financial measures Today's Agenda © 2025 Alpha Teknova, Inc. ● Financial Results | Q1:2025 ● Slide Supplement May 8, 2025 2 Statements in this presentation about future expectations, plans, and prospects, as well as ...
Teknova Reports First Quarter 2025 Financial Results
GlobeNewswire News Room· 2025-05-08 20:01
First quarter 2025 total revenue was $9.8 million, up 5% from prior yearCompany introduced proprietary PluriFreeze™ cryopreservation system, in collaboration with Pluristyx, Inc.Company reaffirms 2025 revenue guidance of $39-42 million HOLLISTER, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova” or the “Company”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today an ...